Literature DB >> 3421292

Long-term reduction of intraocular pressure after repeat argon laser trabeculoplasty.

D K Grayson1, C B Camras, S M Podos, J S Lustgarten.   

Abstract

Thirty-eight eyes (in 31 patients with glaucoma) that had shown a favorable response to an initial argon laser trabeculoplasty had a repeat laser trabeculoplasty four to 81 months (mean +/- S.E.M., 23 +/- 3 months) later because of inadequately controlled intraocular pressures. A mean (+/- S.E.M.) of 65 +/- 3 burns (range, 50 to 115) were given during the initial laser trabeculoplasty, and 58 +/- 2 burns (range, 36 to 100) were given during the first repeat treatment. Three months after the first repeat laser trabeculoplasty, one eye (3%) had undergone filtering surgery and 30 eyes (78%) were considered successes. Of the 30 eyes that were followed up for 12 months after the first repeat laser trabeculoplasty, two (7%) had undergone filtering surgery, three (10%) had received a second repeat laser trabeculoplasty, and 22 (73%) were successes. Fifteen eyes underwent a second repeat laser trabeculoplasty at six to 47 months (mean +/- S.E.M., 21 +/- 3 months) after the first repeat laser trabeculoplasty. Seven (47%) of these eyes required filtering surgery within three to 12 months after the second repeat laser trabeculoplasty. Four of 38 (11%) of the initial, two of 38 (5%) of the first repeat, and zero of 15 of the second repeat laser trabeculoplasty treatments resulted in a one- to two-hour rise in intraocular pressure of at least 10 mm Hg.

Entities:  

Mesh:

Year:  1988        PMID: 3421292     DOI: 10.1016/0002-9394(88)90367-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  The role of apraclonidine hydrochloride in laser therapy for glaucoma.

Authors:  A L Robin
Journal:  Trans Am Ophthalmol Soc       Date:  1989

2.  Update on laser trabeculoplasty.

Authors:  Fathi El Sayyad; Magdi Helal
Journal:  Middle East Afr J Ophthalmol       Date:  2009-07

3.  Efficacy and safety of indomethacin 0.1% versus flurbiprofen 0.03% eyedrops in inflammation after argon laser trabeculoplasty. The Belgian Study Group on Glaucoma.

Authors:  M Goethals; L Missotten
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

4.  Clinical options for the reduction of elevated intraocular pressure.

Authors:  Laura Crawley; Sohaib M Zamir; Maria F Cordeiro; Li Guo
Journal:  Ophthalmol Eye Dis       Date:  2012-04-30

5.  Low-energy Selective Laser Trabeculoplasty Repeated Annually: Rationale for the COAST Trial.

Authors:  Tony Realini; Gus Gazzard; Mark Latina; Michael Kass
Journal:  J Glaucoma       Date:  2021-07-01       Impact factor: 2.290

6.  Repeatability of selective laser trabeculoplasty for open-angle glaucoma.

Authors:  Brian A Francis; Nils Loewen; Bryan Hong; Laurie Dustin; Kevin Kaplowitz; Robert Kinast; Jason Bacharach; Sunita Radhakrishnan; Andrew Iwach; Lidiya Rudavska; Parul Ichhpujani; L Jay Katz
Journal:  BMC Ophthalmol       Date:  2016-07-28       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.